Reuters Gilead said on Sunday it had agreed to acquire the cancer-drug company Immunomidics for 21 billion. Immunomedic shares rose 106% on Monday following the news. Immunomidics, used to treat various forms of breast cancer, sells Drodelvi and is being evaluated for other possible signs of cancer. Trodelvie was approved …
Read More »
Bill Pugliano / Getty The 5 70,570 million bet on Berkshire Hathaway’s Snowflake shows that CEO Werner Buffett has full confidence in his two portfolio managers, Todd Kombs and Ted Wessler, a fund manager says. “Buffett has given his lieutenants full agency,” Jack Taylor, CEO of Farnam Street Investments and …
Read More »
Reuters Bloomberg reported on Thursday that social capital Hidosophia Holdings Corp. II, the “blank check” is being discussed in public by Openandur through a partnership with the company or SPAC, Bloomberg reported on Thursday. Opendur is a property technology company that buys homes directly from sellers, makes some improvements to …
Read More »
NEW YORK (Reuters) – Some of Wall Street’s biggest players are looking at the stock market’s recent tech-led selloff as a means of instability rather than a long slide – and they don’t see it as a reason to run. The door. File photo: February 10, 2009, A street sign …
Read More »
AP Images Warren Buffett’s Berkshire Hathaway on Sunday announced a 5% stake in five Japanese trading houses. Itochu, Marubeni, Mitsubishi, Mitsui, And Sumitomo’s combined was 9 96.9 billion as of Wednesday’s close. Billionaire investors may have been fascinated by their frustrated appraisals and sporadic operations, and may have seen them …
Read More »